OTCMKTS:EXDI Exactus (EXDI) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range$0.07▼$0.0752-Week Range N/AVolume257,300 shsAverage Volume83,144 shsMarket Capitalization$38.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Exactus alerts: Email Address Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. About Exactus Stock (OTCMKTS:EXDI)Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.Read More Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. EXDI Stock News HeadlinesSeptember 6 at 2:01 AM | americanbankingnews.comMariMed (OTCMKTS:MRMD) & Exactus (OTCMKTS:EXDI) Head-To-Head ReviewAugust 4, 2024 | lse.co.ukIsh Msci France Regulatory NewsSeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.February 7, 2024 | news.yahoo.comClapham chemical attack – live: Suspect Abdul Ezedi was ‘very angry’ after sister was shot deadJune 4, 2023 | investing.comStarbreeze AB B (STZEb)October 30, 2021 | finanznachrichten.deExactus Inc.: CBD Company Panacea Life Sciences Sees Promise as Denver Airport Reaches Third-Highest Passenger Traffic in WorldOctober 26, 2021 | finance.yahoo.comExactus, Inc. to Present at BIO CEO & Investor ConferenceOctober 15, 2021 | finanznachrichten.deExactus Inc.: Grand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State UniversitySeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.October 14, 2021 | finance.yahoo.comGrand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State UniversitySee More Headlines Receive EXDI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Exactus and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & Botanicals Sub-IndustryN/A Current SymbolOTCMKTS:EXDI CUSIPN/A CIK1552189 Webwww.exactusinc.com Phone804-205-5036FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,460,000.00 Net MarginsN/A Pretax Margin-15,131.74% Return on Equity-3,272.69% Return on Assets-185.29% Debt Debt-to-Equity RatioN/A Current Ratio1.32 Quick Ratio0.82 Sales & Book Value Annual Sales$2.07 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.09) per share Price / BookN/AMiscellaneous Outstanding Shares599,005,000Free Float209,652,000Market Cap$38.94 million OptionableNot Optionable Beta4.21 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesEmiliano AloiPresident and Interim CEOKenneth E. PuzderChief Financial Officer and DirectorAndrew JohnsonChief Strategy OfficerBobby YampolskyInterim ChairmanKey CompetitorsFitLife BrandsNASDAQ:FTLFJushiOTCMKTS:JUSHFMariMedOTCMKTS:MRMDTrue DrinksOTCMKTS:TRUUBright GreenNASDAQ:BGXXView All Competitors EXDI Stock Analysis - Frequently Asked Questions When did Exactus' stock split? Exactus's stock reverse split on the morning of Thursday, October 28th 2021. The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 28th 2021. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of Exactus? Shares of EXDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Exactus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Exactus investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX) and Entasis Therapeutics (ETTX). This page (OTCMKTS:EXDI) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exactus Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Exactus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EXDI Stock Alerts